SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy.
De Mattia E, Canzonieri V, Polesel J, Mezzalira S, Dalle Fratte C, Dreussi E, Roncato R, Bignucolo A, Innocente R, Belluco C, Pucciarelli S, De Paoli A, Palazzari E, Toffoli G, Cecchin E.
De Mattia E, et al. Among authors: cecchin e.
Front Pharmacol. 2021 Dec 24;12:778781. doi: 10.3389/fphar.2021.778781. eCollection 2021.
Front Pharmacol. 2021.
PMID: 35002714
Free PMC article.